US President Donald Trump announced deals with nine major pharmaceutical companies on Friday to lower US drug prices in exchange for three-year exemptions from threatened tariffs on pharmaceutical imports.The agreements bring the total number of drugmakers aligned with Trump’s pricing initiative to 14 of the 17 companies the administration targeted…
When a single airline carries nearly two-thirds of India’s domestic passengers and two apps handle more than four out…
Consumers planning to buy a new PC or smartphone next year may face higher prices, and the reason is…
The approach of 2026 is sharpening attention on one of the most consequential decisions in US economic policy: who…
Gold prices pared losses from earlier in the day as softer-than-expected US inflation data raised hopes of Federal Reserve…
Citing stronger-than-expected yields in Siberia, agricultural consultancy SovEcon has revised its 2025 Russian wheat production forecast upwards.The agricultural consultancy…
European markets wrapped up Thursday with policymakers, regulators, and dealmakers all in focus.The ECB opted for stability as growth…
The S&P 500 appears poised to snap a four-day losing streak on Thursday as unexpectedly cooler inflation data reignited…
President Donald Trump signed an executive order on Thursday directing federal agencies to reclassify marijuana from Schedule I to…